Antagonists to insulin receptor tyrosine kinase inhibitor

Details Antagonists to insulin receptor tyrosine kinase inhibitor Antagonists to insulin receptor tyrosine kinase inhibitor

1995-07-19

1999-10-19

Hutzell, Paula K.

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

4241411, 5303871, 5303881, A61K 39395, C07K 1600

Patent

active

059685085

ABSTRACT:
A method of diagnosing insulin resistance and related disorders is provided. Additionally, methods of treating mammals with insulin resistance and related disorders is provided. The methods employ antagonists to an insulin receptor tyrosine kinase inhibitor protein.

REFERENCES:
patent: 4748018 (1988-05-01), Stolle et al.
patent: 5124147 (1992-06-01), Wissner et al.
Stefan, et al. 1996. Diabetes, 45: 980-983.
Borrebaeck, Carl A.K., "Strategy for the production of human monoclonal antibodies using in vitro activated B cells" J. Immunol. Methods 123:157-165 (1989).
Buckley et al., "Plasma Cell Membrane Glycoprotein PC-1" Journal of Biological Chemistry 265(29):17506-17511 (1990).
Costantino et al., "Insulin-Resistant MDA-MB231 Human Breast Cancer Cells Contain a Tyrosine Kinase Inhibiting Activity" Molecular Endocrinology 7(12):1667-1676 (1993).
Elliott et al., "Treatment of Rheumatoid Arthritis With Chimeric Monoclonal Antibodies to Tumor Necrosis Factor .alpha." Arthritis and Rheumatism 36(12):1681-1690 (1993).
Funakoshi et al., "Molecular Cloning of cDNAs for Human Fibroblast Nucleotide Pyrophosphatase" Arch. of Biochem. and Biophys. 295(1):180-187 (1992).
Goding, "Antibody Production by Hybridomas" Journal of Immunological Methods 39:285-308 (1980).
Goldfine, Ira D., "The Insulin Receptor: Molecular Biology and Transmembrane Signaling" Endocr Rev. 8(3):235-255 (1987).
Goodman, "Immunogenicity & Antigenic Specificity" Basic and Clinical Immunology pp. 32-40 (1976).
Grupe et al., "Inhibition of Insulin Receptor Phosphorylation by PC-1 is Not Mediated by the Hydrolysis of Adenosine Triphosphate or the Generation of Adenosine" Journal of Biological Chemistry 270(38):22085-22088 (1995).
Grupe et al., "Transgenic Knockouts Reveal a Critical Requirement for Pancreatic .beta. Cell Glucokinase in Maintaining Glucose Homeostasis" Cell 83:69-78 (1995).
Harris et al., "Therapeutic Antibodies--The Coming of Age" TIBTECH 11:42-44 (Feb. 1993).
Huang et al., "Expression of the Murine Plasma Cell Nucleotide Pyrophosphohydrolase PC-1 is Shared by Human Liver, Bone, and Cartilage Cells" J. Clin. Invest. 94:560-567 (1994).
Itoh et al., "Localization of Prohormone Convertase (PC-1 and PC-2) in the Human and Rat Pancreatic Islets" Acta Histochem. Cytochem. (Abstract No. 123) 27(4):406 (1994).
Maddux et al., "Inhibitors of Insulin Receptor Tyrosine Kinase in Fibroblasts from Diverse Patients with Impaired Insulin Action: Evidence for a Novel Mechanism of Postreceptor Insulin Resistance" J. Clin. Endocrin. Metabol. 77(1):73-79 (1993).
Maddux et al., "Membrane Glycoprotein PC-1 and Insulin Resistance in Non-Insulin-Dependent Diabetes Mellitus" Nature 373:448-451 (1995).
Moller, D.E. & Flier, J.S., "Mechanisms of Disease: Insulin Resistance-Mechanisms, Syndromes and Implications" New England J. of Medicine 325(13):938-948 (1991).
Oda et al., "The Plasma Cell Membrane Glycoprotein, PC-1, Is a Threonine-Specific Protein Kinase Stimulated by Acidic Fibroblast Growth Factor" Journal of Biological Chemistry 266(25):16791-16795 (1991).
Osband et al., "Problems in the investigational study and clinical use of cancer immunotherapy" Immunology Today 11(6):193-195 (1990).
Rebbe et al., "Expression of Nucleotide Pyrophosphatase and Alkaline Phosphodiesterase I Activities of PC-1, the Murine Plasma Cell Antigen" Molecular Immunology 30(1):87-93 (1993).
Sbraccia et al., "Production of Inhibitor of Insulin-Receptor Tyrosine Kinase in Fibroblasts from Patient with Insulin Resistance and NIDDM" Diabetes 40:295-299 (1991).
Seino S et al., "Perspectives in Diabetes: Human Insulin-Receptor Gene" Diabetes 39:129-133 (1990).
Sevier et al., "Monoclonal Antibodies in Clinical Immunology" Clinical Chemistry 27(11):1797-1806 (1981).
Stearne et al., "The Murine Plasma Cell Antigen PC-1: Purification and Partial Amino Acid Sequence" J. Immunol. 134(1):443-448 (1985).
Waldmann, T., "Monoclonal Antibodies in Diagnosis and Therapy" Science 252:1657-1662 (Jun. 1991).
Woody et al., "Effective Clinical Therapy of Cardiovascular and Autoimmune Diseases with Chimerized Monoclonal Antibodies" IBC's Second Annual Int'l Conference on Commercializing Human Monoclonal Antibodies (abstract only)San Diego, CA:2:35 (1994).
Yano et al., "Immunoaffinity Purification and Characterization of Nucleotide Pyrophosphatase from Human Placenta" Biochem. and Biophy. Res. Comm. 147(3):1061-1069 (1987).
Feinstein, R. et al. Dec. 5, 1993. J. Biol. Chem. 268 : 26055-26058.
Osband, M.E. et al. 1990. Immunol. Today 11: 193-195.
Shisheva, A. et al. 1994. Endocrinol. 134: 507-510.

Affiliated with

Also associated with

Rating

Antagonists to insulin receptor tyrosine kinase inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antagonists to insulin receptor tyrosine kinase inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antagonists to insulin receptor tyrosine kinase inhibitor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2052087